First Trust NYSE Arca Biotechnology Index Fund (FBT) Stock

FBT

First Trust NYSE Arca Biotechnology Index Fund FBT · AMEX

$265.47 +0.71% (+$1.87)

Summary

First Trust NYSE Arca Biotechnology Index Fund is an ETF - a fund traded on an exchange like a stock - run by First Trust. Positions inside: 31. The ten largest make up 35% of the fund.

Yearly costs: 0.55%
Fund size: $2.90B
Positions: 31
Running since: 2006

What speaks for it

A large fund with $2.90B under management.
Easy to buy and sell: about $19.9M changes hands a day.
Average yearly growth over the last ten years: 11%.
It has been running since 2006.

What to watch

100% of the fund is in one sector (Healthcare).
83% of the fund is in one country (United States).
Costs of 0.55% a year are above the middle of comparable funds (0.44%).
In the last five years its price once dropped by 33% from its high.

A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.

1 month: -1.0%
3 months: +8.2%
This year: +29%
1 year: +40%
3 years: +92%
5 years: +62%
10 years: +194%

Avg. market cap: $38.1B
P/E: 30.1x
Forward P/E: 24.8x
P/S: 4.5x
P/B: 3.8x
P/FCF: 25.2x
EV/EBITDA: 23.8x
Dividend yield: 0.20%
ROIC: 7.2%
ROE: 13.8%
Gross margin: 78.4%
Operating margin: 13.8%
Net margin: 11.6%
Payout ratio: 6.0%
Net debt/EBITDA: 3.3x
Beta: 0.76

Weighted average of the 30 largest companies, which make up 100% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.

What is inside?

Moderately concentrated

1
HA
Halozyme Therapeutics HALO 3.7%
2
RE
Regeneron Pharmaceuticals REGN 3.6%
3
ON
BeOne Medicines AG ONC 3.5%
4
AM
Amgen AMGN 3.5%
5
EX
Exelixis EXEL 3.5%
6
GI
Gilead Sciences GILD 3.5%
7
BI
Biogen BIIB 3.5%
8
AD
ADMA Biologics ADMA 3.5%
9
NE
NeoGenomics, Inc. NEO 3.4%
10
AL
Alkermes ALKS 3.4%

Positions in the fund: 31. The ten largest make up 35% of it.

Composition as of Oct 18, 2026.

Where is it spread?

One sector dominates

By sector

Healthcare 100%

By country

United States 83%
Switzerland 3.5%
Ireland 3.4%
Denmark 3.4%
Other countries 6.5%

By company size

Mega cap 3.5%
Large cap 70%
Mid cap 26%

By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.

Largest sector: Healthcare (100%). Largest country: United States (83%). Largest size group: Large cap (70%).

What does it cost me?

Expensive

This fund 0.55%

Middle of comparable ETFs 0.44%

A year from $10,000: $55.00
Over 20 years: $2,646

From every $10,000 invested the fund takes $55.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,646.

How has it done?

Growing over the long run

-3.6%

-4.8%

+2.5%

+5.2%

+24%

20212022202320242025

A year on average, 10 years: +11%
Deepest drop: -33%
Yearly volatility: 22%

Average yearly growth over the last ten years: 11%. Deepest drop in these years: 33% below the earlier high.

Does it pay dividends?

Yes, it pays out

0.00

1.17

0.00

20212022202320242025

Last payment: $1.17

The last payment was $1.17 on Dec 13, 2024.

Is it easy to buy and sell?

Very easy

Traded a day: $19.9M
Shares a day: 75K

On an average day about $19.9M of the fund changes hands.

How expensive are the companies inside?

Rather expensive

P/E of the companies inside: 30.1
Average Bulios Score: 57 out of 100

Weight by Bulios Fair Price

Undervalued 30%
Fairly valued 10%
Overvalued 60%

On average the companies inside trade for 30.1 times their yearly profit. By Fair Price, 60% of the rated weight comes out as overvalued.

Counted from its largest companies (30), which make up 100% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.

Similar funds

Funds that hold much of the same. The overlap says how much of their weight they share with this fund.

Fund	Domicile		Size	1-year change	Dividends
PB PBE Invesco Biotechnology & Genome ETF	United States	0.59%	$292.3M	+32%	Pays out	48%
IB IBB iShares Biotechnology ETF	United States	0.44%	$10.5B	+30%	Pays out	44%
BB BBH VanEck Biotech ETF	United States	0.35%	$486.7M	+35%	Pays out	41%
FT FTXH First Trust Nasdaq Pharmaceuticals ETF	United States	0.60%	$1.11B	+41%	Pays out	35%
SB SBIO.MI Invesco NASDAQ Biotech UCITS ETF	Ireland	0.40%	$568.8M	+37%	Reinvests	33%
IB IBBQ Invesco Nasdaq Biotechnology ETF	United States	0.19%	$79.9M	+30%	Pays out	33%